M28 Capital Management LP Long-Term Concentrated

CIK: 0001807489 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 10, 2023

Total Value ($000): $104,910 (100.0% shares, 0.0% debt)

Holdings (14)

WVE WAVE LIFE SCIENCES LTD 39.4%

Value ($000) $41,324 Shares 5,903,405 Est. Cost $3.07 Unrealized +50.1%

RCKT ROCKET PHARMACEUTICALS INC 13.5%

Value ($000) $14,131 Shares 722,080 Est. Cost $23.75 Unrealized -22.4%

IVVD INVIVYD INC 13.2%

Value ($000) $13,872 Shares 9,248,250 Est. Cost $17.64 Unrealized -84.2%

PRQR PROQR THRAPEUTICS N V 6.7%

Value ($000) $7,069 Shares 1,910,600 Est. Cost $2.38 Unrealized -45.0%

ARWR ARROWHEAD PHARMACEUTICALS IN 5.6%

Value ($000) $5,837 Shares 143,900 Est. Cost $33.13 Unrealized 0.0%

IONS IONIS PHARMACEUTICALS INC 4.5%

Value ($000) $4,770 Shares 126,300 Est. Cost $42.06 Unrealized 0.0%

STOK STOKE THERAPEUTICS INC 4.2%

Value ($000) $4,457 Shares 482,890 Est. Cost $23.86 Unrealized -56.4%

BBIO BRIDGEBIO PHARMA INC 3.0%

Value ($000) $3,193 Shares 419,000 Est. Cost $39.38 Unrealized -75.7%

— SPRINGWORKS THERAPEUTICS INC 2.7%

Value ($000) $2,858 Shares 109,900 Est. Cost $26.01 Unrealized —

— CURIS INC 2.3%

Value ($000) $2,465 Shares 4,482,142 Est. Cost $3.68 Unrealized —

SLN SILENCE THERAPEUTICS PLC 2.1%

Value ($000) $2,225 Shares 145,900 Est. Cost $15.25 Unrealized —

— ATARA BIOTHERAPEUTICS INC 1.4%

Value ($000) $1,441 Shares 439,300 Est. Cost $3.28 Unrealized —

TGTX TG THERAPEUTICS INC 1.2%

Value ($000) $1,235 Shares 104,400 Est. Cost $18.81 Unrealized -61.4%

— NEXIMMUNE INC 0.0%

Value ($000) $32 Shares 133,442 Est. Cost $4.61 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
WVE	WAVE LIFE SCIENCES LTD	5,903,405	$41,324	39.4%	$3.07	+50.1%	SHS	Y95308105
RCKT	ROCKET PHARMACEUTICALS INC	722,080	$14,131	13.5%	$23.75	-22.4%	COM	77313F106
IVVD	INVIVYD INC	9,248,250	$13,872	13.2%	$17.64	-84.2%	COM	00534A102
PRQR	PROQR THRAPEUTICS N V	1,910,600	$7,069	6.7%	$2.38	-45.0%	SHS EURO	N71542109
ARWR	ARROWHEAD PHARMACEUTICALS IN	143,900	$5,837	5.6%	$33.13	0.0%	COM	04280A100
IONS	IONIS PHARMACEUTICALS INC	126,300	$4,770	4.5%	$42.06	0.0%	COM	462222100
STOK	STOKE THERAPEUTICS INC	482,890	$4,457	4.2%	$23.86	-56.4%	COM	86150R107
BBIO	BRIDGEBIO PHARMA INC	419,000	$3,193	3.0%	$39.38	-75.7%	COM	10806X102
—	SPRINGWORKS THERAPEUTICS INC	109,900	$2,858	2.7%	$26.01	—	COM	85205L107
—	CURIS INC	4,482,142	$2,465	2.3%	$3.68	—	COM NEW	231269200
SLN	SILENCE THERAPEUTICS PLC	145,900	$2,225	2.1%	$15.25	—	ADS	82686Q101
—	ATARA BIOTHERAPEUTICS INC	439,300	$1,441	1.4%	$3.28	—	COM	046513107
TGTX	TG THERAPEUTICS INC	104,400	$1,235	1.2%	$18.81	-61.4%	COM	88322Q108
—	NEXIMMUNE INC	133,442	$32	0.0%	$4.61	—	COM	65344D109